Newcastle Disease and Avian Influenza Vaccine, Inactivated (H5+H9 Subtypes)
2.3.2.1b/2.3.2.1e/2.3.4.4b/2.3.4.4c/2.3.4.4e/2.3.4.4h
4.1.a and 4.1.b or 4.2.5.
- Indication / Application:For prevention of: Newcastle disease (sub-genotype VII), Avian Influenza (H9N2 and H5 clades 2.3.4.4h and 2.3.4.4b).
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Newcastle Disease and Avian Influenza Vaccine, Inactivated (H5+H9 Subtypes)
Composition and Content
| Disease | Strain | Antigen Content | Optional Strain(s) |
|---|---|---|---|
| ND | La Sota | ≥ 108.5 EID50/0.1ml | La Sota + A-VII |
| AI(H9N2) | Clade 9.4.2.5 | ≥ 108.5 EID50/0.1ml | H9 (9.4.1a); H9 (9.4.1b) |
| AI(H5) | H5N6 (2.3.4.4h) | ≥ 108.5 EID50/0.1ml |
H5N6 (2.3.4.4b and 2.3.4.4h); H5N1 (2.3.4.4b); H5N1 (2.3.2.1c); H5N1 (2.2.1); H5 (2.3.4.4c) |
| H5N8 (2.3.4.4b) | ≥ 108.5 EID50/0.1ml |
Indications
For the prevention of Newcastle disease (La Sota strain), avian influenza caused by H9N2 subtype clade 4.2.5, and avian influenza caused by H5 subtype clades 2.3.4.4h and 2.3.4.4b in poultry. Immunity develops 14 days after vaccination. Duration of immunity: 6 months in chickens and 4 months in ducks and geese; a booster is required 3 weeks after the primary vaccination.
Dosage and Administration
Administration: inject intramuscularly in the breast or subcutaneously in the neck. Chickens 2-5 weeks of age: 0.3 mL; adult chickens over 5 weeks: 0.5 mL; ducklings and goslings 2-5 weeks: 0.5 mL; adult ducks and geese over 5 weeks: 1.0 mL.
Adverse Reactions
Generally, no adverse reactions occur.
Specification
250 mL/bottle; 500 mL/bottle.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
A uniform milky-white emulsion.
Precautions
- 1. For vaccination of healthy chickens only.
- 2. Do not freeze. Do not use if the emulsion has separated.
- 3. Shake thoroughly and allow the vaccine to reach room temperature before use.
- 4. Use the vaccine on the day the vial is first opened.
- 5. Disinfect needles and other equipment before use.
- 6. Dispose of used vaccine vials, equipment, and remaining vaccine safely.
Due to significant variations in the prevalent H5 avian influenza strains across different regions, we can adjust the H5 and H9 Avian Influenza antigen combinations according to customer requirements to achieve optimal disease prevention effects.
H5 subtype clades: 2.3.2.1b/2.3.2.1e/2.3.4.4b/2.3.4.4c/2.3.4.4e/2.3.4.4h
H9N2 subtype clade 4.1.a and 4.1.b or 4.2.5.